Skip to content
OpenSampling

2020 · The AAPS journal · open access

Land O'Lakes Workshop on Microsampling: Enabling Broader Adoption

Wickremsinhe et al.

The finding, in our words

This workshop report provides recommendations on blood sampling sites, bridging study design, and statistical methods for correlation to support the adoption of microsampling in patient-centric drug development. It emphasises the critical need for away-from-clinic sampling techniques to maintain patient safety during the COVID-19 pandemic.

A paraphrase to the Library’s standard, never the abstract. The source is one link away and is always the authority.

Labels

  1. 2024

    Capillary blood collection using liquid and dried microsampling devices yielded pharmacokinetic profiles comparable to venous sampling for two monoclonal antibodies and a small molecule, whereas haematocrit correction was necessary for dried formats and bridging was ineffective for hydroxychloroquine. The findings demonstrate the bioanalytical feasibility and patient acceptability of remote microsampling tools for pharmacokinetic evaluations in decentralised clinical trials.

    Evaluation of Patient-Centric Sample Collection Technologies for Pharmacokinetic Assessment of Large and Small MoleculesMandlekar et al., Clinical pharmacology and therapeutics (paywalled) · source ↗

    • blood
    • liquid
    • dried
    • capillary
    • neoteryx-mitra
    • validation
    • venous-agreement
    • acceptability
    • tdm
    • biologics
    • dct
    • haematocrit
  2. 2021

    Capillary blood collected by fingerstick showed near-perfect correlation with venous samples for HbA1c (R² = 0.993), with 96.7% of paired results differing by no more than 0.2%. Most participants found the kit easy to use at home, indicating potential for decentralised diabetes monitoring when in-person visits are impractical.

    Comparison of central laboratory HbA1c measurements obtained from a capillary collection versus a standard venous whole blood collection in the GRADE and EDIC studiesNathan et al., PloS one · source ↗

    • blood
    • liquid
    • capillary
    • validation
    • venous-agreement
    • acceptability
    • dct
  3. 2026

    Guidance on capillary-to-plasma conversion: method- and analyte-specific clinical validation with paired capillary–venous samples before reporting plasma-equivalent results.

    To Convert or Not to Convert? Official IATDMCT Guideline on Converting Capillary-Blood Microsampling Concentrations to Plasma ConcentrationsBoffel et al., Therapeutic Drug Monitoring (paywalled) · source ↗

    • venous-agreement
    • blood
    • tdm
    • standards
    • dried
    • capillary
    • validation
  4. 2026

    At-home volumetric absorptive microsampling (VAMS) for anti-seizure medicines was feasible and reliable, with strong correlations to clinic VAMS and low bias for lacosamide, lamotrigine and levetiracetam; quantitative dried blood spot (qDBS) was a reliable alternative in the ambulatory setting, though older age reduced sampling quality.

    Real-world evaluation of capillary microsampling for drug monitoring of anti-seizure medicationsCancellerini et al., Epilepsia (paywalled) · source ↗

    • vams
    • venous-agreement
    • acceptability
    • blood
    • qdbs
    • tdm
    • self-collection
    • dried
    • capillary
  5. 2026

    The study found that although participants preferred patient-centric microsampling devices for home use, the agreement with venous plasma for measuring CRP and cytokines was inconsistent, indicating that further validation is required before these methods replace standard venipuncture.

    Limited agreement of cytokines and CRP through patient-centric microsampling compared to venipuncture in healthy adultsTuttle et al., Bioanalysis (paywalled) · source ↗

    • dct
    • venous-agreement
    • acceptability
    • blood
    • dbs
    • self-collection
    • dried
    • biomarkers